Tetrahydrocannabinol and endocannabinoids in feeding and appetite

被引：144

作者：

Berry, EM

Mechoulam, R ^{[1
]}

机构：

[1] Hebrew Univ Jerusalem, Fac Med, Dept Med Chem & Nat Prod, IL-91120 Jerusalem, Israel

[2] Hebrew Univ Jerusalem, Sch Publ Hlth, Dept Human Nutr & Metab, IL-91120 Jerusalem, Israel

来源：

PHARMACOLOGY & THERAPEUTICS | 2002年 / 95卷 / 02期

关键词：

anandamide; 2-arachidonoylglycerol; leptin; SR141716A; suckling; cannabinoid receptors;

D O I：

10.1016/S0163-7258(02)00257-7

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The physiological control of appetite and satiety, in which numerous neurotransmitters and neuropeptides play a role, is extremely complex. Here we describe the involvement of endocannabinoids in these processes. These endogenous neuromodulators enhance appetite in animals. The same effect is observed in animals and in humans with the psychotropic plant cannabinoid Delta(9)-tetrahydrocannabinol, which is an approved appetite-enhancing drug. The CB1 cannabinoid receptor antagonist SR141716A blocks the effects on feeding produced by the endocannabinoids. If administered to mice pups, this antagonist blocks suckling, In obese humans, it causes weight reduction. Very little is known about the physiological and biochemical mechanisms involved in the effects of Delta(9)-tetrahydrocannabinol and the cannabinoids in feeding and appetite. (C) 2002 Elsevier Science Inc. All rights reserved.

引用

页码：185 / 190

页数：6

共 63 条

[11]

British Nutrition Foundation, 1992, UNS FATT AC

[12]

Calhoun SR, 1998, J PSYCHOACTIVE DRUGS, V30, P187

[13] Behavioral effects of cannabinoid agents in animals [J].